Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.
Trends Cell Biol. 2024 Apr;34(4):327-337. doi: 10.1016/j.tcb.2023.07.009. Epub 2023 Aug 12.
The cystine transporter solute carrier family 7 member 11 (SLC7A11) (also known as xCT) promotes glutathione synthesis and counters oxidative stress-induced cell death, including ferroptosis, by importing cystine. Also, SLC7A11 plays a crucial role in tumor development. However, recent studies have uncovered an unexpected role of SLC7A11 in promoting disulfidptosis, a novel form of regulated cell death induced by disulfide stress. In this review, we examine the opposing roles of SLC7A11 in regulating redox homeostasis and cell survival/death, summarize current knowledge on disulfidptosis, and explore its potential in disease treatment. A deeper understanding of disulfidptosis will offer new insights into fundamental cellular homeostasis and facilitate the development of innovative therapies for disease treatment.
胱氨酸转运蛋白溶质载体家族 7 成员 11(SLC7A11)(也称为 xCT)通过导入胱氨酸促进谷胱甘肽合成,并抵抗氧化应激诱导的细胞死亡,包括铁死亡。此外,SLC7A11 在肿瘤发展中起着至关重要的作用。然而,最近的研究揭示了 SLC7A11 在促进二硫键应激诱导的新型调控细胞死亡形式——二硫键蛋白毒性(disulfidptosis)中的意外作用。在这篇综述中,我们研究了 SLC7A11 在调节氧化还原平衡和细胞存活/死亡中的相反作用,总结了目前关于二硫键蛋白毒性的知识,并探讨了其在疾病治疗中的潜力。深入了解二硫键蛋白毒性将为基本细胞内稳态提供新的见解,并促进疾病治疗的创新疗法的发展。